Facebook Twitter RSS
  • Search this Website
 
Skip to content
  • About Us
    • Our Vision
    • Intervention Strategies
    • Member – Government Committees
    • Annual Reports
    • Our Trustees
    • Donors
    • FCRA Information
  • Our Work
    • Pandemics and COVID-19
      • Helplines
      • Statements
      • High Court Order
      • Articles
      • Community Voices
      • Relief & Other Support for Covid-19
      • Intersectional Feminist Framework
      • Consultations on Gender, Equity & Covid-19 Vaccines
      • Webinar Series Pandemics & Public Health
      • Webinar Series on Vaccine Research & Access
      • Webinars on Covid-19
      • Videos and Podcasts
    • Public Health & Right to Health
    • Surrogacy & ARTs
      • Conference Participation & Seminars
      • Workshops & Discussions
      • Reports & Studies
      • Consultations
      • Film / Media
      • Policy Level Advocacy
      • Publications
      • Media Resources
    • Gender Based Violence
    • Sexual and Reproductive Health
    • Ethics in Clinical Trials, Access to Medicines
    • Young Women and Mental Health
    • Bioethics
    • Early Marriage and Health
    • Population Policies & Two Child Norm
  • Publications
    • Research Reports
    • Consultation Reports
    • Policy Briefs
    • Capacity Building Tools
    • Fact Finding Reports
    • Articles and Edited Volumes
    • Posters
    • Films & Videos
  • Archives
    • Clinical Trials
      • General
      • Affordability
      • Availability & Accessability
      • Compensation
      • Informed Consent
      • Recuritment
      • Bioethics
      • Guidelines & Legislations
  • Photo Gallery
  • Contact
  • Internship
  • Support Us

Category: Bioethics

‘Guinea pig’ fear after trial cloud on three hospitals – Institutes accused of violating guidelines

  By admin Archives, Bioethics, Clinical Trials

G. S. Mudur | The Telegraph | 26 November 2012 Three hospitals in India violated clinical guidelines while testing a drug on patients with heart disease in a trial that a medical expert said also illustrates how India’s lax regulatory… Continue reading

The social function of clinical equipoise

  By admin Archives, Bioethics, Clinical Trials

Jonathan Kimmelman | Clinical Trials: Journal of the Society for Clinical Trials | October 2012 | Vol. 9 No. 5, 630-631 The principle of clinical equipoise was first articulated in 1987 by Benjy Freedman. Briefly, the principle holds that trials should… Continue reading

The compulsory licence on sorafenib: A right step to ensure access to medicines

  By admin Archives, Bioethics, Clinical Trials

K. M. Gopakumar | TWN | | Third World Resurgence No. 259 | March 2012, pp 26-28 The Indian Patent Office (IPO) made a landmark order on 12 March to grant domestic drug company Natco Pharma a compulsory licence (CL) to… Continue reading

Post Trial Access and related issues: Data from one (a bit old) study

  By admin Archives, Bioethics, Clinical Trials

Nancy E. Kass | Berman Institute of Bioethics, Bloomberg School of Public Health, Johns Hopkins University | 2011   A presentation made at the workshop titled Post-trial access to trial drugs: Legal, ethical and practical issues held at the Brocher… Continue reading

Post-trial benefits – India

  By admin Archives, Bioethics, Clinical Trials

Amar Jesani | Indian Journal of Medical Ethics | Centre for Studies in Ethics and Rights Mumbai | India | 2011 A presentation made at the workshop titled Post-trial access to trial drugs: Legal, ethical and practical issues held at… Continue reading

Enrolling the un(der)insured in clinical trials: Post-trial access as coercion or due compensation?

  By admin Archives, Bioethics, Clinical Trials

Jill A. Fischer | Centre for Biomedical Ethics & Society | 2011 A presentation made at the workshop titled Post-trial access to trial drugs: Legal, ethical and practical issues held at the Brocher Foundation, Geneva on 15 – 16 December… Continue reading

1234
  • Announcements

    • ​’Working hope: How ASHAs mediate between their communities and the health system’
    • Innovative practices to address GBV in the Asia Pacific region in the pandemic context 
    • Webinar: “Relooking local production and R&D: Why the TRIPS waiver is still relevant”
    • Short course: GBV & Health systems roles and accountability
    • Webinar on Intersectionality and Equity in Intellectual Property Rights in Healthcare
  • What’s New

    • Examining the Contested Political and Economic Landscape of Assisted Reproductive Technology and Surrogacy Regulations in India
    • ​’Working hope: How ASHAs mediate between their communities and the health system’
    • The Unravelling Pandemic: Envisioning our Intersectional Feminist Futures
    • Regulation of Surrogacy in India
    • Dignity in death or discrimination in death?
  • Training, Building Capacities and Leadership

    Our Trainings and Capacity Building activities facilitate mobilization and provide support towards organizing around health issues and promoting health rights. They contribute to … Read more »

  • Research

    Research is an integral component of Sama’s work. Research is carried out on issues that the organization is already advocating around or in situations where we feel that there is a need to initiate … Read more »

  • Advocacy

    Sama recognizes the critical role of advocacy in building collective understanding on various issues and to strengthen and sustain campaigns around them. Advocacy initiatives of Sama, including … Read more »

  • Knowledge Creation

    Sama undertakes Creation of Knowledge Resources and their Dissemination on different issues pertaining to women and health. This forms our core strategy on various issues and initiatives that Sama … Read more »

  • About Us
  • Our Work
  • Publications
  • Archives
  • Photo Gallery
  • Contact
  • Internship
  • Support Us
© Sama – Resource Group for Women and Health, 2021
Powered by Parabola & WordPress.
Facebook Twitter RSS